€68.15
0.44% yesterday
Xetra, Jun 30, 05:35 pm CET
ISIN
DE0005659700
Symbol
EUZ
Index
Sector

Eckert & Ziegler Strahlen- und Medizintechnik Stock price

€68.15
+6.35 10.28% 1M
+23.65 53.15% 6M
+23.65 53.15% YTD
+26.59 63.96% 1Y
+35.26 107.18% 3Y
+34.60 103.11% 5Y
+62.75 1,163.07% 10Y
+65.18 2,190.76% 20Y
Xetra, Closing price Mon, Jun 30 2025
+0.30 0.44%
ISIN
DE0005659700
Symbol
EUZ
Index
Sector

Key metrics

Basic
Market capitalization
€1.4b
Enterprise Value
€1.3b
Net debt
positive
Cash
€118.2m
Shares outstanding
20.9m
Valuation (TTM | estimate)
P/E
41.37 | 29.21
P/S
4.66 | 4.29
EV/Sales
4.44 | 4.09
EV/FCF
25.21
P/B
6.13
Dividends
DPS
€0.50
Yield 1Y | 5Y
0.74% | 0.77%
Growth 1Y | 5Y
1,006.19% | 5.43%
Payout 1Y | 3Y
31.45% | 23.45%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€296.4m | €321.8m
EBITDA
€82.2m | €98.2m
EBIT
€63.3m
Net Income
€34.5m | €48.4m
Free Cash Flow
€52.2m
Growth (TTM | estimate)
Revenue
15.89% | 8.78%
EBITDA
25.63% | 39.83%
EBIT
22.39%
Net Income
14.78% | 45.52%
Free Cash Flow
319.37%
Margin (TTM | estimate)
Gross
47.98%
EBITDA
27.73% | 30.50%
EBIT
21.36%
Net
11.63% | 15.05%
Free Cash Flow
17.60%
Financial Health
Equity Ratio
50.51%
Return on Equity
14.89%
ROCE
16.94%
ROIC
16.60%
Debt/Equity
0.23
More
EPS
€1.64
FCF per Share
€2.50
Short interest
-
Employees
1.09k
Rev per Employee
€270.00k
Show more

Is Eckert & Ziegler Strahlen- und Medizintechnik a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.

Eckert & Ziegler Strahlen- und Medizintechnik Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Eckert & Ziegler Strahlen- und Medizintechnik forecast:

4x Buy
67%
2x Hold
33%

Analyst Opinions

6 Analysts have issued a Eckert & Ziegler Strahlen- und Medizintechnik forecast:

Buy
67%
Hold
33%

Financial data from Eckert & Ziegler Strahlen- und Medizintechnik

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
296 296
16% 16%
100%
- Direct Costs 154 154
17% 17%
52%
142 142
15% 15%
48%
- Selling and Administrative Expenses 73 73
11% 11%
25%
- Research and Development Expense - -
-
-
82 82
26% 26%
28%
- Depreciation and Amortization 19 19
38% 38%
6%
EBIT (Operating Income) EBIT 63 63
22% 22%
21%
Net Profit 34 34
15% 15%
12%

In millions EUR.

Don't miss a Thing! We will send you all news about Eckert & Ziegler Strahlen- und Medizintechnik directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eckert & Ziegler Strahlen- und Medizintechnik Stock News

AD HOC NEWS
13 days ago
Eckert & Ziegler SE / DE0005659700
AD HOC NEWS
13 days ago
Eckert & Ziegler SE / DE0005659700
AD HOC NEWS
26 days ago
Eckert & Ziegler SE / DE0005659700
More Eckert & Ziegler Strahlen- und Medizintechnik News

Company Profile

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, and Radiopharma. The Radiation Therapy segment includes the production and distribution of medical products for the treatment of cancer using brachytherapy. The Isotope Products segment manufactures and distributes sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment is specialized in the field of molecular imaging and nuclear medicine, supplying different radiopharmaceuticals, radiochemicals and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Head office Germany
CEO Harald Hasselmann
Employees 1,085
Founded 1997
Website www.ezag.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today